PPARGC1A and chronic obstructive pulmonary disease: Compared with healthy controls, patients with COPD had lower PGC-1α mRNA expression in skeletal muscle, accompanied by reduced TFAM protein levels, which may be linked to decreased muscle oxidation capacity in COPD (Remels et al., 2007).